[Monoclonal antibody therapy in breast cancer]. / Monoklonális antitest-terápia emlõrákban.
Magy Onkol
; 57(3): 157-65, 2013 Sep.
Article
em Hu
| MEDLINE
| ID: mdl-24107821
ABSTRACT
A new trend has been taking place in the daily oncology practice in the past twenty years we are progressively moving toward individualized and personalized treatments. The treatment of breast cancer is one of the best examples to underline the outstanding effectiveness of the individualized approach. The modern molecular pathology features are capable of predicting the biological behavior of the tumors which gives a new basis for our therapeutic choices, both for neoadjuvant and adjuvant settings, as well as for metastatic disease. In our paper we review the currently used monoclonal antibodies in the treatment of breast cancer and provide an overview of the new research and future directions in this field.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Terapia de Alvo Molecular
/
Anticorpos Monoclonais Humanizados
/
Antineoplásicos
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Limite:
Female
/
Humans
Idioma:
Hu
Ano de publicação:
2013
Tipo de documento:
Article